Table 2 Clinical characteristics of included pediatric patients with congenital heart disease
Patient | Age (years) | Sex | Primary diagnosis | Indication for CMR |
|---|---|---|---|---|
1 | 9 | w | IAA, LVOTO, VSD, ASD | Evaluation of graft stenosis after Yasui procedure |
2 | 6 | m | TOF with PA, MAPCAs | Follow up after TOF repair (progressive right ventricular remodeling) |
3 | 9 | w | TOF, MAPCAs | Regular follow up after TOF repair |
4 | 9 | m | HLHS with AA, AVSD | Follow-up after Fontan procedure (Hypoxemia episodes) |
5 | 4 | m | TA, restrictive BVF, PVS, ASD | Evaluation before Fontan procedure |
6 | 2 | m | HLHC with MS and AS, AAH | Evaluation before Fontan procedure |
7 | 6 | m | TOF with PA | Follow up after TOF repair (decreasing physical capacity) |
8 | 8 | m | TOF | Follow up after TOF repair (low physical capacity) |
9 | 9 months | w | DORV, PS, VSD | Progression of heart failure |
10 | 5 | m | TOF with PA, MAPCA | Evaluation after TOF repair and before surgery |
11 | 2 | w | DILV, DOLV, PA, VSD | Evaluation before Fontan procedure |
12 | 2 | m | TOF, ASD | Follow up after TOF repair (decreasing physical capacity) |
13 | 5 | m | HLHS | Evaluation before Fontan procedure |
14 | 5 | m | TOF, VSD | Follow up after TOF repair (moderate physical capacity) |
15 | 7 | m | Bicuspid aortic valve, AI | Critical AI |
16 | 4 | w | HLHS | Evaluation before Fontan procedure |
17 | 4 | m | DORV, VSD, ASD | Regular follow up after surgery/intervention |
18 | 5 | m | DILV, L-TGA, PS | Regular follow up after Fontan procedure |
19 | 2 | w | TA | Evaluation before Fontan procedure |
20 | 5 | m | HLHS (MA, AA), MAPCA | Evaluation before Fontan procedure |
21 | 5 | w | Suspected scimitar syndrome | Confirmation of PAPVC |
22 | 2 | w | HLHS (MA, AA), ASD | Evaluation before Fontan procedure |
23 | 4 | w | PA, MAPCAs | Evaluation before Fontan procedure |
24 | 3 | m | Unbalanced AVSD, ISTA | Evaluation before Fontan procedure |
25 | 2 | w | HLHS, VSD, ISTA | Evaluation before Fontan procedure |
26 | 6 | m | TOF, MAPCAs | Evaluation after TOF repair and before intervention |
27 | 4 | m | TAC, TS, VSD, ASD | Evaluation before Fontan procedure |
28 | 7 | m | Right atrial isomerism, AVSD, TAPVC, D-TGA | Regular follow up after Fontan procedure |
29 | 3 | w | DILV, L-TGA, ASD, ISTA | Evaluation before Fontan procedure |
30 | 5 | w | PA, VSD, ASD | Evaluation before Fontan procedure |
31 | 2 | w | TA, VSD, restrictive BVF, PVS | Evaluation before Fontan procedure |
32 | 4 | w | ASD, suspected PAPVC | Confirmation of diagnosis |
33 | 4 | w | Ebstein’s anomaly, PFO | Progression of heart failure |
34 | 4 | m | PA, VSD, ASD | Follow up after graft exchange |
35 | 2 | m | DORV, L-TGA, VSD, PFO | Evaluation before surgery (hypoxemia episodes) |
36 | 1 | w | Sinus venosus ASD, suspected PAPVC | Confirmation of diagnosis |